BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20716692)

  • 1. Milnacipran for treatment of fibromyalgia.
    Kyle JA; Dugan BD; Testerman KK
    Ann Pharmacother; 2010 Sep; 44(9):1422-9. PubMed ID: 20716692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
    Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain.
    Leo RJ; Brooks VL
    Curr Opin Investig Drugs; 2006 Jul; 7(7):637-42. PubMed ID: 16869117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Milnacipran: beyond a role of antidepressant.
    Pae CU; Marks DM; Shah M; Han C; Ham BJ; Patkar AA; Masand PS
    Clin Neuropharmacol; 2009; 32(6):355-63. PubMed ID: 19620845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milnacipran for neuropathic pain and fibromyalgia in adults.
    Derry S; Gill D; Phillips T; Moore RA
    Cochrane Database Syst Rev; 2012 Mar; 3(3):CD008244. PubMed ID: 22419330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial.
    Arnold LM; Gendreau RM; Palmer RH; Gendreau JF; Wang Y
    Arthritis Rheum; 2010 Sep; 62(9):2745-56. PubMed ID: 20496365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.
    Clauw DJ; Mease P; Palmer RH; Gendreau RM; Wang Y
    Clin Ther; 2008 Nov; 30(11):1988-2004. PubMed ID: 19108787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.
    Häuser W; Urrútia G; Tort S; Uçeyler N; Walitt B
    Cochrane Database Syst Rev; 2013 Jan; (1):CD010292. PubMed ID: 23440848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study.
    Branco JC; Cherin P; Montagne A; Bouroubi A;
    J Rheumatol; 2011 Jul; 38(7):1403-12. PubMed ID: 21459941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milnacipran for pain in fibromyalgia in adults.
    Cording M; Derry S; Phillips T; Moore RA; Wiffen PJ
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008244. PubMed ID: 26482422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia.
    Branco JC; Zachrisson O; Perrot S; Mainguy Y;
    J Rheumatol; 2010 Apr; 37(4):851-9. PubMed ID: 20156949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of milnacipran on clinical pain and hyperalgesia of patients with fibromyalgia: results of a 6-week randomized controlled trial.
    Staud R; Lucas YE; Price DD; Robinson ME
    J Pain; 2015 Aug; 16(8):750-9. PubMed ID: 25998206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Milnacipran: in fibromyalgia.
    Chwieduk CM; McCormack PL
    Drugs; 2010; 70(1):99-108. PubMed ID: 20030428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium.
    Bernstein CD; Albrecht KL; Marcus DA
    Expert Opin Pharmacother; 2013 May; 14(7):905-16. PubMed ID: 23506481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.
    Mease PJ; Clauw DJ; Gendreau RM; Rao SG; Kranzler J; Chen W; Palmer RH
    J Rheumatol; 2009 Feb; 36(2):398-409. PubMed ID: 19132781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of milnacipran in patients with fibromyalgia.
    Gendreau RM; Thorn MD; Gendreau JF; Kranzler JD; Ribeiro S; Gracely RH; Williams DA; Mease PJ; McLean SA; Clauw DJ
    J Rheumatol; 2005 Oct; 32(10):1975-85. PubMed ID: 16206355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibromyalgia, milnacipran and experimental pain modulation: study protocol for a double blind randomized controlled trial.
    Macian N; Pereira B; Shinjo C; Dubray C; Pickering G
    Trials; 2015 Apr; 16():134. PubMed ID: 25873248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resting state connectivity correlates with drug and placebo response in fibromyalgia patients.
    Schmidt-Wilcke T; Ichesco E; Hampson JP; Kairys A; Peltier S; Harte S; Clauw DJ; Harris RE
    Neuroimage Clin; 2014; 6():252-61. PubMed ID: 25379438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milnacipran for fibromyalgia.
    Dempsey J
    Issues Emerg Health Technol; 2008 Feb; (114):1-4. PubMed ID: 18354855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACS chemical neuroscience molecule spotlight on savella.
    Hopkins CR
    ACS Chem Neurosci; 2010 May; 1(5):345. PubMed ID: 22778830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.